Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Oral Minoxidil 1 mg vs Topical Regaxidil in Healthy Volunteers
NCT06015516Phase 1Completed
- Sponsor
- Cantabria Labs
- Start
- Feb 2024
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by Cantabria Labs. Primary endpoints: Area Under the Curve From Time Zero to the Last Determination at Day 5, Maximum Observed Plasma Concentration at Day 5 and 1 more. Started Feb 2024; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06015516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06015516.